In November 2022, Australia's medical regulatory company, the Therapeutic Products Administration (TGA) described that there was a worldwide scarcity on the diabetes medication Ozempic. According to the TGA, the increase in demand from customers was due to an increase in off-label prescription of the drug for weight-loss functions.[167] In December https://thomass641jrw6.wikienlightenment.com/user